These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27612145)

  • 1. Predicting 10-Year Risk of Fatal Cardiovascular Disease in Germany: An Update Based on the SCORE-Deutschland Risk Charts.
    Rücker V; Keil U; Fitzgerald AP; Malzahn U; Prugger C; Ertl G; Heuschmann PU; Neuhauser H
    PLoS One; 2016; 11(9):e0162188. PubMed ID: 27612145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicted 10-year risk of cardiovascular mortality in the 40 to 69 year old general population without cardiovascular diseases in Germany.
    Diederichs C; Neuhauser H; Rücker V; Busch MA; Keil U; Fitzgerald AP; Heuschmann PU
    PLoS One; 2018; 13(1):e0190441. PubMed ID: 29293619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory-based and office-based risk scores and charts to predict 10-year risk of cardiovascular disease in 182 countries: a pooled analysis of prospective cohorts and health surveys.
    Ueda P; Woodward M; Lu Y; Hajifathalian K; Al-Wotayan R; Aguilar-Salinas CA; Ahmadvand A; Azizi F; Bentham J; Cifkova R; Di Cesare M; Eriksen L; Farzadfar F; Ferguson TS; Ikeda N; Khalili D; Khang YH; Lanska V; León-Muñoz L; Magliano DJ; Margozzini P; Msyamboza KP; Mutungi G; Oh K; Oum S; Rodríguez-Artalejo F; Rojas-Martinez R; Valdivia G; Wilks R; Shaw JE; Stevens GA; Tolstrup JS; Zhou B; Salomon JA; Ezzati M; Danaei G
    Lancet Diabetes Endocrinol; 2017 Mar; 5(3):196-213. PubMed ID: 28126460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistical modelling of 10-year fatal cardiovascular disease risk in Greece: the HellenicSCORE (a calibration of the ESC SCORE project).
    Panagiotakos DB; Fitzgerald AP; Pitsavos C; Pipilis A; Graham I; Stefanadis C
    Hellenic J Cardiol; 2007; 48(2):55-63. PubMed ID: 17489342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a recalibrated Systematic Coronary Risk Evaluation cardiovascular risk chart: results from Systematic Coronary Risk Evaluation Germany.
    Hense HW; Koesters E; Wellmann J; Meisinger C; Völzke H; Keil U
    Eur J Cardiovasc Prev Rehabil; 2008 Aug; 15(4):409-15. PubMed ID: 18677164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular risk age: concepts and practicalities.
    Cooney MT; Vartiainen E; Laatikainen T; De Bacquer D; McGorrian C; Dudina A; Graham I;
    Heart; 2012 Jun; 98(12):941-6. PubMed ID: 22626902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recalibration of the SCORE risk chart for the Russian population.
    Jdanov DA; Deev AD; Jasilionis D; Shalnova SA; Shkolnikova MA; Shkolnikov VM
    Eur J Epidemiol; 2014 Sep; 29(9):621-8. PubMed ID: 25179794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recalibration and validation of the SCORE risk chart in the Australian population: the AusSCORE chart.
    Chen L; Tonkin AM; Moon L; Mitchell P; Dobson A; Giles G; Hobbs M; Phillips PJ; Shaw JE; Simmons D; Simons LA; Fitzgerald AP; De Backer G; De Bacquer D
    Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):562-70. PubMed ID: 19741542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A competing risk approach for the European Heart SCORE model based on cause-specific and all-cause mortality.
    Støvring H; Harmsen CG; Wisløff T; Jarbøl DE; Nexøe J; Nielsen JB; Kristiansen IS
    Eur J Prev Cardiol; 2013 Oct; 20(5):827-36. PubMed ID: 22498473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of Framingham and SCORE-based cardiovascular risk estimates in participants of the German National Health Interview and Examination Survey 1998.
    Neuhauser HK; Ellert U; Kurth BM
    Eur J Cardiovasc Prev Rehabil; 2005 Oct; 12(5):442-50. PubMed ID: 16210930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of an Australian cardiovascular disease mortality risk score using multiple imputation and recalibration from national statistics.
    Backholer K; Hirakawa Y; Tonkin A; Giles G; Magliano DJ; Colagiuri S; Harris M; Mitchell P; Nelson M; Shaw JE; Simmons D; Simons L; Taylor A; Harding J; Gopinath B; Woodward M
    BMC Cardiovasc Disord; 2017 Jan; 17(1):17. PubMed ID: 28061760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive accuracy and usefulness of calibration of the ESC SCORE in Switzerland.
    Marques-Vidal P; Rodondi N; Bochud M; Pécoud A; Hayoz D; Paccaud F; Mooser V; Waeber G; Vollenweider P
    Eur J Cardiovasc Prev Rehabil; 2008 Aug; 15(4):402-8. PubMed ID: 18677163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Dutch SCORE-based risk charts seriously underestimate the risk of cardiovascular disease.
    Jørstad HT; Boekholdt SM; Wareham NJ; Khaw KT; Peters RJ
    Neth Heart J; 2017 Mar; 25(3):173-180. PubMed ID: 27943174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of WHO updated cardiovascular disease risk prediction charts in a low-resource setting - Findings from a community-based survey in Puducherry, India.
    Sivanantham P; Kar SS; Lakshminarayanan S; Sahoo JP; Bobby Z; Varghese C
    Nutr Metab Cardiovasc Dis; 2022 Sep; 32(9):2129-2136. PubMed ID: 35752538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimated prevalence of cardiovascular disease and distribution of cardiovascular risk in New Zealanders: data for healthcare planners, funders, and providers.
    Wells S; Broad J; Jackson R
    N Z Med J; 2006 Apr; 119(1232):U1935. PubMed ID: 16633394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The recalibrated HellenicSCORE based on newly derived risk factors from the Hellenic National Nutrition and Health Survey (HNNHS); the HellenicSCORE II.
    Panagiotakos DB; Magriplis E; Zampelas A; ;
    Hellenic J Cardiol; 2021; 62(4):285-290. PubMed ID: 32311430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of total cardiovascular risk using the 2019 WHO CVD prediction charts and comparison of population-level costs based on alternative drug therapy guidelines: a population-based study of adults in Bangladesh.
    Islam JY; Zaman MM; Moniruzzaman M; Ara Shakoor S; Hossain AHME
    BMJ Open; 2020 Jul; 10(7):e035842. PubMed ID: 32690512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum 25-hydroxyvitamin D and incidence of fatal and nonfatal cardiovascular events: a prospective study with repeated measurements.
    Perna L; Schöttker B; Holleczek B; Brenner H
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4908-15. PubMed ID: 24106288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Model for estimation of cardiovascular risk in Norway].
    Selmer R; Lindman AS; Tverdal A; Pedersen JI; Njølstad I; Veierød MB
    Tidsskr Nor Laegeforen; 2008 Jan; 128(3):286-90. PubMed ID: 18264151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of the cardiovascular risk using World Health Organization/International Society of Hypertension (WHO/ISH) risk prediction charts in a rural population of South India.
    Ghorpade AG; Shrivastava SR; Kar SS; Sarkar S; Majgi SM; Roy G
    Int J Health Policy Manag; 2015 Apr; 4(8):531-6. PubMed ID: 26340393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.